Literature DB >> 18334100

Cannabinoid concentrations in spot serum samples 24-48 hours after discontinuation of cannabis smoking.

Gisela Skopp1, Lucia Pötsch.   

Abstract

A blood concentration of tetrahydrocannabinol (THC) in the low nanograms-per-milliliter range is often claimed to result from drug use more than 24-48 h previously. The present investigation determined concentrations of cannabinoids in blood collected at least 24 h from smoking in an in-patient setting. During sampling, distinctive effects due to drug use could not be observed. The randomly collected samples from heavy (n = 16, > 1 joint/day), moderate (n = 15, < or = 1 joint/day), and light (n = 6, < 1 joint/week) users of cannabis were analyzed for THC, 11-hydroxy-THC (OH-THC), and free 11-nor-9-carboxy-THC (THCCOOH) by gas chromatography-mass spectrometry as well as for glucuronidated THCCOOH by liquid chromatography-tandem mass spectrometry. THC was detectable in 9, 6, and 1 samples from heavy, moderate, and light users, respectively. Although cannabinoid concentrations were overlapping between groups, there was a trend towards higher concentrations of both conjugated and free THCCOOH in regular users compared to occasional users. The present findings appear to indicate that low levels of THC, or of THC along with OH-THC, may not unequivocally prove a very recent use of cannabis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18334100     DOI: 10.1093/jat/32.2.160

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  15 in total

1.  Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.

Authors:  David M Schwope; Erin L Karschner; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2011-08-11       Impact factor: 8.327

2.  Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010.

Authors:  Joanne E Brady; Guohua Li
Journal:  Am J Epidemiol       Date:  2014-01-29       Impact factor: 4.897

3.  Re: "trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010".

Authors:  Rebecca L Hartman; Marilyn A Huestis
Journal:  Am J Epidemiol       Date:  2014-09-21       Impact factor: 4.897

Review 4.  A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics.

Authors:  Emily J Cox; Neha Maharao; Gabriela Patilea-Vrana; Jashvant D Unadkat; Allan E Rettie; Jeannine S McCune; Mary F Paine
Journal:  Pharmacol Ther       Date:  2019-05-07       Impact factor: 12.310

5.  Delta-9 THC can be detected and quantified in the semen of men who are chronic users of inhaled cannabis.

Authors:  Malinda S Lee; Andrea Lanes; Elizabeth S Ginsburg; Janis H Fox
Journal:  J Assist Reprod Genet       Date:  2020-04-30       Impact factor: 3.412

6.  Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.

Authors:  Erin L Karschner; David M Schwope; Eugene W Schwilke; Robert S Goodwin; Deanna L Kelly; David A Gorelick; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2012-03-29       Impact factor: 4.492

7.  Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

Authors:  Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

8.  Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Ronald I Herning; Jean Lud Cadet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

Review 9.  The pharmacokinetics and the pharmacodynamics of cannabinoids.

Authors:  Catherine J Lucas; Peter Galettis; Jennifer Schneider
Journal:  Br J Clin Pharmacol       Date:  2018-08-07       Impact factor: 4.335

10.  Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Harrison G Pope; Ronald Herning; Jean L Cadet; Marilyn A Huestis
Journal:  Addiction       Date:  2009-10-05       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.